|
1
|
Shen L, Shan YS, Hu HM, Price TJ, Sirohi
B, Yeh KH, Yang YH, Sano T, Yang HK, Zhang X, et al: Management of
gastric cancer in Asia: Resource-stratified guidelines. Lancet
Oncol. 14:e535–e547. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Leung WK, Wu MS, Kakugawa Y, et al: Asia
Pacific Working Group on Gastric Cancer: Screening for gastric
cancer in Asia: current evidence and practice. Lancet Oncol.
9:279–287. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang WH, Huang JQ, Zheng GF, Lam SK,
Karlberg J and Wong BC: Non-steroidal anti-inflammatory drug use
and the risk of gastric cancer: a systematic review and
meta-analysis. J Natl Cancer Inst. 95:1784–1791. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kılınçalp S, Ekiz F, Başar O, Ayte MR,
Coban S, Yılmaz B, Altınbaş A, Başar N, Aktaş B, Tuna Y, et al:
Mean platelet volume could be possible biomarker in early diagnosis
and monitoring of gastric cancer. Platelets. 25:592–594. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mroczko B, Wereszczyñska-Siemiatkowska U,
Groblewska M, Lukaszewicz M, Szmitkowski M, Gryko M and Kedra B:
The diagnostic value of hematopoietic cytokines measurement in the
sera of gastric cancer and gastric ulcer patients. Clin Chim Acta.
374:165–167. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mroczko B, Groblewska M, Łukaszewicz-Zajac
M, Bandurski R, Kedra B and Szmitkowski M: Pre-treatment serum and
plasma levels of matrix metalloproteinase 9 (MMP-9) and tissue
inhibitor of matrix metalloproteinases 1 (TIMP-1) in gastric cancer
patients. Clin Chem Lab Med. 47:1133–1139. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kemal Y, Yucel I, Ekiz K, Demirag G,
Yilmaz B, Teker F and Ozdemir M: Elevated serum neutrophil to
lymphocyte and platelet to lymphocyte ratios could be useful in
lung cancer diagnosis. Asian Pac J Cancer Prev. 15:2651–2654. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lian L, Li W, Li ZY, Mao YX, Zhang YT,
Zhao YM, Chen K, Duan WM and Tao M: Inhibition of MCF-7 breast
cancer cell-induced platelet aggregation using a combination of
antiplatelet drugs. Oncol Lett. 5:675–680. 2013.PubMed/NCBI
|
|
9
|
Egan K, Crowley D, Smyth P, O'Toole S,
Spillane C, Martin C, Gallagher M, Canney A, Norris L, Conlon N, et
al: Platelet adhesion and degranulation induce pro-survival and
pro-angiogenic signalling in ovarian cancer cells. PLoS One.
6:e261252011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tsuruo T and Fujita N: Platelet
aggregation in the formation of tumor metastasis. Proc Jpn Acad Ser
B Phys Biol Sci. 84:189–198. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Seretis C, Seretis F, Lagoudianakis E,
Politou M, Gemenetzis G and Salemis NS: Enhancing the accuracy of
platelet to lymphocyte ratio after adjustment for large platelet
count: a pilot study in breast cancer patients. Int J Surg Oncol.
2012:6536082012.PubMed/NCBI
|
|
12
|
Cho SY, Yang JJ, You E, Kim BH, Shim J,
Lee HJ, Lee WI, Suh JT and Park TS: Mean platelet volume/platelet
count ratio in hepatocellular carcinoma. Platelets. 24:375–377.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kemal Y, Demirag G, Ekiz K and Yucel I:
Mean platelet volume could be a useful biomarker for monitoring
epithelial ovarian cancer. J Obstet Gynaecol. 34:515–518. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mutlu H, Berk V, Karaca H, Erden A, Aslan
T and Akca Z: Treatment regimen with bevacizumab decreases mean
platelet volume in patients with metastatic colon cancer. Clin Appl
Thromb Hemost. 18:546–548. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Aksoy S, Kilickap S, Hayran M,
Harputluoglu H, Koca E, Dede DS, Erman M and Turker A: Platelet
size has diagnostic predictive value for bone marrow metastasis in
patients with solid tumors. Int J Lab Hematol. 30:214–219. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Eisenhauer EA, Therasse P, Bogaerts J,
Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S,
Mooney M, et al: New response evaluation criteria in solid tumours:
revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–247.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bazou D, Santos-Martinez MJ, Medina C and
Radomski MW: Elucidation of flow-mediated tumour cell-induced
platelet aggregation using an ultrasound standing wave trap. Br J
Pharmacol. 162:1577–1589. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Heras P, Hatzopoulos A, Kritikos N and
Kritikos K: Platelet count and tumor progression in gastric cancer
patients. Scand J Gastroenterol. 45:1005–1006. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Karagöz B, Bilgi O, Alacacioğlu A, Ozgün
A, Sayan O, Erikçi AA and Kandemir EG: Mean platelet volume
increase after tamoxifen, but not after anastrazole in adjuvant
therapy of breast cancer. Med Oncol. 27:199–202. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mutlu H, Artis TA, Erden A and Akca Z:
Alteration in mean platelet volume and platicrit values in patients
with cancer that developed thrombosis. Clin Appl Thromb Hemost.
19:331–333. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Matowicka-Karna J, Kamocki Z, Polińska B,
Osada J and Kemona H: Platelets and inflammatory markers in
patients with gastric cancer. Clin Dev Immunol. 2013:4016232013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
McMillan DC: Systemic inflammation,
nutritional status and survival in patients with cancer. Curr Opin
Clin Nutr Metab Care. 12:223–226. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shou LM, Zhang QY, Li W, et al:
Cantharidin and norcantharidin inhibit the ability of MCF-7 cells
to adhere to platelets via protein kinase C pathway-dependent
downregulation of α2 integrin. Oncol Rep. 30:1059–1066.
2013.PubMed/NCBI
|
|
24
|
Ilhan N, Ilhan N, Ilhan Y, Akbulut H and
Kucuksu M: C-reactive protein, procalcitonin, interleukin-6,
vascular endothelial growth factor and oxidative metabolites in
diagnosis of infection and staging in patients with gastric cancer.
World J Gastroenterol. 10:1115–1120. 2004.PubMed/NCBI
|
|
25
|
Lochhead P and El-Omar EM: Gastric cancer.
Br Med Bull. 85:87–100. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hussain SP and Harris CC: Inflammation and
cancer: an ancient link with novel potentials. Int J Cancer.
121:2373–2380. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Galizia G, Lieto E, De Vita F, et al:
Circulating levels of interleukin-10 and interleukin-6 in gastric
and colon cancer patients before and after surgery: relationship
with radicality and outcome. J Interferon Cytokine Res. 22:473–482.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shariat SF, Andrews B, Kattan MW, Kim J,
Wheeler TM and Slawin KM: Plasma levels of interleukin-6 and its
soluble receptor are associated with prostate cancer progression
and metastasis. Urology. 58:1008–1015. 2001. View Article : Google Scholar : PubMed/NCBI
|
